Bank of America
HZNP

Bank of America’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bank of America’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,025,402
Closed -$119M – 8435
2023
Q3 		$119M Buy
1,025,402
+355,925
+53% +$38.2M 0.01% 805
2023
Q2 		$68.9M Sell
669,477
-1,714,118
-72% -$181M 0.01% 1092
2023
Q1 		$260M Buy
2,383,595
+877,096
+58% +$96.9M 0.03% 523
2022
Q4 		$171M Buy
1,506,499
+245,610
+19% +$20.4M 0.02% 659
2022
Q3 		$78M Sell
1,260,889
-267,255
-17% -$18.7M 0.01% 971
2022
Q2 		$122M Buy
1,528,144
+137,249
+10% +$13M 0.01% 790
2022
Q1 		$146M Sell
1,390,895
-201,369
-13% -$19.6M 0.01% 771
2021
Q4 		$172M Sell
1,592,264
-45,111
-3% -$4.92M 0.02% 741
2021
Q3 		$179M Buy
1,637,375
+8,118
+0.5% +$843K 0.02% 687
2021
Q2 		$153M Sell
1,629,257
-29,716
-2% -$2.73M 0.02% 754
2021
Q1 		$153M Sell
1,658,973
-19,481
-1% -$1.64M 0.02% 686
2020
Q4 		$123M Buy
1,678,454
+500,374
+42% +$37.2M 0.02% 698
2020
Q3 		$91.5M Buy
1,178,080
+202,656
+21% +$13.9M 0.01% 767
2020
Q2 		$54.2M Buy
975,424
+34,739
+4% +$1.49M 0.01% 989
2020
Q1 		$27.9M Buy
940,685
+33,902
+4% +$1.15M 0.01% 1294
2019
Q4 		$32.8M Buy
906,783
+158,009
+21% +$4.84M ﹤0.01% 1471
2019
Q3 		$20.4M Sell
748,774
-220,635
-23% -$5.7M ﹤0.01% 1812
2019
Q2 		$23.3M Buy
969,409
+270,212
+39% +$6.85M ﹤0.01% 1733
2019
Q1 		$18.5M Sell
699,197
-435,857
-38% -$10.3M ﹤0.01% 1899
2018
Q4 		$22.2M Sell
1,135,054
-1,090,464
-49% -$21.4M ﹤0.01% 1583
2018
Q3 		$43.6M Sell
2,225,518
-90,095
-4% -$1.71M 0.01% 1195
2018
Q2 		$38.3M Buy
2,315,613
+617,595
+36% +$9.42M 0.01% 1280
2018
Q1 		$24.1M Sell
1,698,018
-806,225
-32% -$11.9M ﹤0.01% 1611
2017
Q4 		$36.6M Sell
2,504,243
-611,157
-20% -$8.58M 0.01% 1329
2017
Q3 		$39.5M Buy
3,115,400
+2,341,756
+303% +$29.8M 0.01% 1323
2017
Q2 		$9.18M Buy
773,644
+56,206
+8% +$699K ﹤0.01% 2454
2017
Q1 		$10.6M Buy
717,438
+151,765
+27% +$2.46M ﹤0.01% 2320
2016
Q4 		$9.15M Sell
565,673
-163,803
-22% -$2.97M ﹤0.01% 2392
2016
Q3 		$13.2M Buy
729,476
+252,558
+53% +$4.93M ﹤0.01% 1979
2016
Q2 		$7.85M Buy
476,918
+14,919
+3% +$241K ﹤0.01% 2422
2016
Q1 		$7.66M Sell
461,999
-5,149
-1% -$90.1K ﹤0.01% 2392
2015
Q4 		$10.1M Sell
467,148
-37,874
-7% -$737K ﹤0.01% 2242
2015
Q3 		$10M Buy
505,022
+465,107
+1,165% +$14.7M ﹤0.01% 2217
2015
Q2 		$1.39M Buy
39,915
+8,419
+27% +$257K ﹤0.01% 3829
2015
Q1 		$818K Buy
31,496
+15,511
+97% +$284K ﹤0.01% 3923
2014
Q4 		$206K Sell
15,985
-3,072
-16% -$38.5K ﹤0.01% 5346
2014
Q3 		$234K Buy
19,057
+16,921
+792% +$197K ﹤0.01% 5263
2014
Q2 		$34K Sell
2,136
-1,944
-48% -$27.7K ﹤0.01% 6907
2014
Q1 		$62K Sell
4,080
-731
-15% -$8.26K ﹤0.01% 6302
2013
Q4 		$37K Buy
4,811
+3,743
+350% +$20.2K ﹤0.01% 6739
2013
Q3 		$4K Sell
1,068
-16,004
-94% -$42.2K ﹤0.01% 7480
2013
Q2 		$42K Buy
+17,072
New +$41K ﹤0.01% 6662

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's HZNP Position: Q4 2023 in Review

Bank of America sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,025,402 shares — an estimated $119M sold.

Bank of America first reported a position in HZNP in Q2 2013 and held it in 42 quarters. The position peaked at $260M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Bank of America reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Bank of America sold 1,025,402 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $119M.
  • Bank of America first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 42 quarters.
  • Bank of America's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $260M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.